[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@Perspective_Tx](/creator/twitter/Perspective_Tx) "We are on the ground at the European Society for Medical Oncology Congress 2025 (#ESMO25) in Berlin Germany We will be presenting updated interim results from our Phase 1/2a study of 212PbVMT--NET on Monday Oct. XX at 8:58AM CEST. For more: $CATX" [X Link](https://x.com/Perspective_Tx/status/1979995998479880556) [@Perspective_Tx](/creator/x/Perspective_Tx) 2025-10-19T19:40Z XXX followers, XXX engagements "Earlier today Perspective presented updated interim results from its Phase 1/2a study of 212PbVMT--NET at #ESMO25. There will be a conference call today to discuss the data at 8:30AM ET. For more details on the presentation and conference call: $CATX" [X Link](https://x.com/Perspective_Tx/status/1980236379188769246) [@Perspective_Tx](/creator/x/Perspective_Tx) 2025-10-20T11:35Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Perspective_Tx
"We are on the ground at the European Society for Medical Oncology Congress 2025 (#ESMO25) in Berlin Germany We will be presenting updated interim results from our Phase 1/2a study of 212PbVMT--NET on Monday Oct. XX at 8:58AM CEST. For more: $CATX"
X Link @Perspective_Tx 2025-10-19T19:40Z XXX followers, XXX engagements
"Earlier today Perspective presented updated interim results from its Phase 1/2a study of 212PbVMT--NET at #ESMO25. There will be a conference call today to discuss the data at 8:30AM ET. For more details on the presentation and conference call: $CATX"
X Link @Perspective_Tx 2025-10-20T11:35Z XXX followers, XXX engagements
/creator/twitter::1684919119819251712/posts